The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor
Open accessAbstract
St. John's wort ( Hypericum perforatum ) is an herbal remedy used widely for the treatment of depression. Recent clinical studies demonstrate that hypericum extracts increase the metabolism of various drugs, including combined oral contraceptives, cyclosporin, and indinavir. In this report, we show that hyperforin, a constituent of St. John's wort with antidepressant activity, is a potent ligand ( K i = 27 nM) for the pregnane X receptor, an orphan nuclear receptor that regulates expression of the cytochrome P450 (CYP) 3A4 monooxygenase. Treatment of primary human hepatocytes with hypericum extracts or hyperforin results in a marked induction of CYP3A4 expression. Because CYP3A4 is involved in the oxidative metabolism of >50% of all drugs, our findings provide a molecular mechanism for the interaction of St. John's wort with drugs and suggest that hypericum extracts are likely to interact with many more drugs than previously had been realized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., & Kliewer, S. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3703 · Cited by 1,576
Self-citationAn Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway
Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterström, R. H., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80900-9 · Cited by 1,539
Self-citationFugh-Berman, A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06457-0 · Cited by 1,099
St John's wort for depression—an overview and meta-analysis of randomised clinical trials
Linde, K., Ramirez, G., Mulrow, C. D., Pauls, A., Weidenhammer, W., & Melchart, D. (1996) · BMJ · doi:10.1136/bmj.313.7052.253 · Cited by 989
SXR, a novel steroid and xenobioticsensing nuclear receptor
Blumberg, B., Sabbagh, W., Juguilon, H., Bolado, J., van Meter, C. M., Ong, E. S., & Evans, R. M. (1998) · Genes & Development · doi:10.1101/gad.12.20.3195 · Cited by 919
(2006) · Pharmacodynamic Basis of Herbal Medicine, Second Edition · doi:10.1201/9781420006452.ch4 · Cited by 905
Indinavir concentrations and St John's wort
Piscitelli, S. C., Burstein, A. H., Chaitt, D., Alfaro, R. M., & Falloon, J. (2000) · The Lancet · doi:10.1016/s0140-6736(99)05712-8 · Cited by 874
Identification of a human nuclear receptor defines a new signaling pathway for CYP 3 A induction
Bertilsson, G., Heidrich, J., Svensson, K., Åsman, M., Jendeberg, L., Sydow-Bäckman, M., Ohlsson, R., Postlind, H., Blomquist, P., & Berkenstam, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12208 · Cited by 872
The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during Evolution
Jones, S. A., Moore, L. B., Shenk, J. L., Wisely, G. B., Hamilton, G. A., McKee, D. D., Tomkinson, N. C. O., LeCluyse, E. L., Lambert, M. H., Willson, T. M., et al. (2000) · Molecular Endocrinology · doi:10.1210/me.14.1.27 · Cited by 672
Self-citationAcute heart transplant rejection due to Saint John's wort
Ruschitzka, F., Meier, P. J., Turina, M., Lüscher, T. F., & Noll, G. (2000) · The Lancet · doi:10.1016/s0140-6736(99)05467-7 · Cited by 644
Cited by
Clinical importance of the cytochromes P450
Nebert, D. W., & Russell, D. W. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11203-7 · Cited by 1,414
Role of P-Glycoprotein in Pharmacokinetics: Clinical Implications
Lin, J. H., & Yamazaki, M. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342010-00003 · Cited by 998
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
Desta, Z., Zhao, X., Shin, J.-G., & Flockhart, D. A. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241120-00002 · Cited by 942
The Nuclear Pregnane X Receptor: A Key Regulator of Xenobiotic Metabolism
Kliewer, S. A., Goodwin, B., & Willson, T. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0038 · Cited by 921
Self-citationKast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109326200 · Cited by 916
Self-citationDietary flavonoids: Effects on xenobiotic and carcinogen metabolism
Moon, Y. J., Wang, X., & Morris, M. E. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2005.06.048 · Cited by 869
The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux
Synold, T. W., Dussault, I., & Forman, B. M. (2001) · Nature Medicine · doi:10.1038/87912 · Cited by 840
Summary of information on human CYP enzymes: human P450 metabolism data
Rendic, S. (2002) · Drug Metabolism Reviews · doi:10.1081/dmr-120001392 · Cited by 820
The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity
Watkins, R. E., Wisely, G. B., Moore, L. B., Collins, J. L., Lambert, M. H., Williams, S. P., Willson, T. M., Kliewer, S. A., & Redinbo, M. R. (2001) · Science · doi:10.1126/science.1060762 · Cited by 760
Self-citationBarnes, J., Anderson, L. A., & Phillipson, J. D. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775910 · Cited by 749
Bile acid receptors as targets for drug development
Schaap, F. G., Trauner, M., & Jansen, P. L. M. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.151 · Cited by 696
Enterohepatic bile salt transporters in normal physiology and liver disease
Kullak-ublick, G. A., Stieger, B., & Meier, P. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.06.005 · Cited by 658
Maglich, J. M., Stoltz, C. M., Goodwin, B., Hawkins-Brown, D., Moore, J. T., & Kliewer, S. A. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.638 · Cited by 654
Self-citationNuclear Receptors and the Control of Metabolism
Francis, G. A., Fayard, E., Picard, F., & Auwerx, J. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142528 · Cited by 636
Herb-Drug Interactions: A Literature Review
Hu, Z., Yang, X., Ho, P. C. L., Chan, S. Y., Heng, P. W. S., Chan, E., Duan, W., Koh, H. L., & Zhou, S. (2005) · Drugs · doi:10.2165/00003495-200565090-00005 · Cited by 633
Polyherbal formulation: Concept of ayurveda
Parasuraman, S., Thing, G., & Dhanaraj, S. (2014) · Pharmacognosy Reviews · doi:10.4103/0973-7847.134229 · Cited by 618
Cancer Chemoprevention by Carotenoids
Tanaka, T., Shnimizu, M., & Moriwaki, H. (2012) · Molecules · doi:10.3390/molecules17033202 · Cited by 589
Binding Affinities of Host–Guest, Protein–Ligand, and Protein–Transition‐State Complexes
Houk, K. N., Leach, A. G., Kim, S. P., & Zhang, X. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200565 · Cited by 586
A Natural Product That Lowers Cholesterol As an Antagonist Ligand for FXR
Urizar, N. L., Liverman, A. B., Dodds, D. T., Silva, F. V., Ordentlich, P., Yan, Y., Gonzalez, F. J., Heyman, R. A., Mangelsdorf, D. J., & Moore, D. D. (2002) · Science · doi:10.1126/science.1072891 · Cited by 549
Reciprocal activation of Xenobiotic response genes by nuclear receptors SXR/PXR and CAR
Xie, W., Barwick, J. L., Simon, C. M., Pierce, A. M., Safe, S., Blumberg, B., Guzelian, P. S., & Evans, R. M. (2000) · Genes & Development · doi:10.1101/gad.846800 · Cited by 508
Willson, T. M., & Kliewer, S. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd753 · Cited by 503
Self-citationHerbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents
Sparreboom, A., Cox, M. C., Acharya, M. R., & Figg, W. D. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.182 · Cited by 473
Induction of Drug Metabolism: The Role of Nuclear Receptors
Handschin, C., & Meyer, U. A. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.2 · Cited by 470
Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties
Rupprecht, R. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00064-1 · Cited by 427
Maglich, J. M., Parks, D. J., Moore, L. B., Collins, J. L., Goodwin, B., Billin, A. N., Stoltz, C. A., Kliewer, S. A., Lambert, M. H., Willson, T. M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300138200 · Cited by 416
Self-citationEffect of St John's Wort on Drug Metabolism by Induction of Cytochrome P450 3A4 Enzyme
Markowitz, J. S. (2003) · JAMA · doi:10.1001/jama.290.11.1500 · Cited by 403
Interactions of Herbs with Cytochrome P450
Zhou, S., Gao, Y., Jiang, W., Huang, M., Xu, A., & Paxton, J. W. (2003) · Drug Metabolism Reviews · doi:10.1081/dmr-120018248 · Cited by 397
Vitamin K2 Regulation of Bone Homeostasis Is Mediated by the Steroid and Xenobiotic Receptor SXR
Tabb, M. M., Sun, A., Zhou, C., Grün, F., Errandi, J., Romero, K., Pham, H., Inoue, S., Mallick, S., Lin, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303136200 · Cited by 387
BAREing it all: the adoption of LXR and FXR and their roles in lipid homeostasis
Edwards, P. A., Kast, H. R., & Anisfeld, A. M. (2002) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)30180-2 · Cited by 385
St John's wort (Hypericum perforatum): drug interactions and clinical outcomes
Henderson, L., Yue, Q. Y., Bergquist, C., Gerden, B., & Arlett, P. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01683.x · Cited by 380
Cytochromes P450, Drugs, and Diseases
Guengerich, F. P. (2003) · Molecular Interventions · doi:10.1124/mi.3.4.194 · Cited by 378
Herbal Modulation of P‐Glycoprotein
Zhou, S., Lim, L. Y., & Chowbay, B. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-120028427 · Cited by 375
Regulation of the Human CYP2B6 Gene by the Nuclear Pregnane X Receptor
Goodwin, B., Moore, L. B., Stoltz, C. M., McKee, D. D., & Kliewer, S. A. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12603-x · Cited by 374
Self-citationOmiecinski, C. J., Vanden Heuvel, J. P., Perdew, G. H., & Peters, J. M. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq338 · Cited by 369
Drug interactions in cancer therapy
Scripture, C. D., & Figg, W. D. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1887 · Cited by 366
Moore, L. B., Maglich, J. M., McKee, D. D., Wisely, B., Willson, T. M., Kliewer, S. A., Lambert, M. H., & Moore, J. T. (2002) · Molecular Endocrinology · doi:10.1210/me.16.5.977 · Cited by 355
Self-citationHuman drug metabolising cytochrome P450 enzymes: properties and polymorphisms
Ingelman-Sundberg, M. (2004) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-003-0819-z · Cited by 353
Cytochrome P450 phenotypic ratios for predicting herb‐drug interactions in humans
Gurley, B. J., Gardner, S. F., Hubbard, M. A., Williams, D. K., Gentry, W. B., Cui, Y., & Ang, C. Y. W. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.126913 · Cited by 343
Pharmacogenetics of warfarin: current status and future challenges
Wadelius, M., & Pirmohamed, M. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500417 · Cited by 330
Regulation of CYP3A Gene Transcription by the Pregnane X Receptor
Goodwin, B., Redinbo, M. R., & Kliewer, S. A. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.111901.111051 · Cited by 327
Self-citationKawabata, K., Mukai, R., & Ishisaka, A. (2015) · Food & Function · doi:10.1039/c4fo01178c · Cited by 326
Mechanisms of Clinically Relevant Drug Interactions Associated with Tacrolimus
Christians, U., Jacobsen, W., Benet, L. Z., & Lampen, A. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241110-00003 · Cited by 323
Pharmacokinetics and Bioavailability of Herbal Medicinal Products
Atul Bhattaram, V., Graefe, U., Kohlert, C., Veit, M., & Derendorf, H. (2002) · Phytomedicine · doi:10.1078/1433-187x-00210 · Cited by 315
Drug–drug interaction mediated by inhibition and induction of P-glycoprotein
Lin, J. H. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00171-0 · Cited by 309
Human Drug Metabolism and the Cytochromes P450: Application and Relevance of In Vitro Models
Venkatakrishnan, K., von Moltke, L. L., & Greenblatt, D. J. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122012724 · Cited by 308
Bauer, B., Hartz, A. M. S., Fricker, G., & Miller, D. S. (2004) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)05623-2 · Cited by 294
Dearing, M. D., Foley, W. J., & McLean, S. (2005) · Annual Review of Ecology, Evolution, and Systematics · doi:10.1146/annurev.ecolsys.36.102003.152617 · Cited by 289
Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects
di Masi, A., Marinis, E. D., Ascenzi, P., & Marino, M. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.04.002 · Cited by 288
Borrelli, F., & Izzo, A. A. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9146-8 · Cited by 288
The interaction between St John's wort and an oral contraceptive
Hall, S. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.08.009 · Cited by 285
Gut microbial metabolites in depression: understanding the biochemical mechanisms
Caspani, G., Kennedy, S., Foster, J. A., & Swann, J. (2019) · Microbial Cell · doi:10.15698/mic2019.10.693 · Cited by 284
Marchetti, S., Mazzanti, R., Beijnen, J. H., & Schellens, J. H. M. (2007) · The Oncologist · doi:10.1634/theoncologist.12-8-927 · Cited by 284
St John's Wort increases expression of P‐glycoprotein: Implications for drug interactions
Hennessy, M., Kelleher, D., Spiers, J. P., Barry, M., Kavanagh, P., Back, D., Mulcahy, F., & Feely, J. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01516.x · Cited by 280
Role of Orphan Nuclear Receptors in the Regulation of Drug-Metabolising Enzymes
Wang, H., & LeCluyse, E. L. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342150-00003 · Cited by 278
St John's wort: Prozac from the plant kingdom
Di Carlo, G., Borrelli, F., Ernst, E., & Izzo, A. A. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01716-8 · Cited by 277
Jiang, X., Williams, K. M., Liauw, W. S., Ammit, A. J., Roufogalis, B. D., Duke, C. C., Day, R. O., & McLachlan, A. J. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2003.02051.x · Cited by 274
Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity
Henderson, G. L., Harkey, M. R., Gershwin, M. E., Hackman, R. M., Stern, J. S., & Stresser, D. M. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00407-5 · Cited by 274
GURLEY, B., GARDNER, S., HUBBARD, M., WILLIAMS, D., GENTRY, W., KHAN, I., & SHAH, A. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.01.009 · Cited by 271
CAR and PXR: Xenosensors of endocrine disrupters?
Kretschmer, X. C., & Baldwin, W. S. (2005) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.06.003 · Cited by 268
CYP induction-mediated drug interactions: in vitro assessment and clinical implications
Lin, J. H. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0277-7 · Cited by 264
Pharmacokinetic variability of anticancer agents
Undevia, S. D., Gomez-Abuin, G., & Ratain, M. J. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1629 · Cited by 258
Effect of St John's wort on imatinib mesylate pharmacokinetics
FRYE, R., FITZGERALD, S., LAGATTUTA, T., HRUSKA, M., & EGORIN, M. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.06.007 · Cited by 258
MDR- and CYP3A4-mediated drug–herbal interactions
Pal, D., & Mitra, A. K. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.010 · Cited by 254
Botanical Medicines — The Need for New Regulations
Marcus, D. M., & Grollman, A. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmsb022858 · Cited by 253
Pharmacokinetic Interactions of Drugs with St John’s Wort
Zhou, S., Chan, E., Pan, S.-Q., Huang, M., & Lee, E. J. D. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104042632 · Cited by 253
Orphan Nuclear Receptors: The Exotics of Xenobiotics
Xie, W., & Evans, R. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100033200 · Cited by 210
Identification of drugs that interact with herbs in drug development
Zhou, S.-F., Zhou, Z.-W., Li, C.-G., Chen, X., Yu, X., Xue, C. C., & Herington, A. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.06.004 · Cited by 178
Gurley, B., Fifer, E., & Gardner, Z. (2012) · Planta Medica · doi:10.1055/s-0031-1298331 · Cited by 165
Herbal medicines in the treatment of psychiatric disorders: a systematic review
Sarris, J. (2007) · Phytotherapy Research · doi:10.1002/ptr.2187 · Cited by 164
Oral Nonprescription Treatment for Insomnia: An Evaluation of Products With Limited Evidence
Meoli, A. L., Rosen, C., Kristo, D., Kohrman, M., Gooneratne, N., Aguillard, R. N., Fayle, R., Troell, R., Townsend, D., Claman, D., et al. (2005) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26314 · Cited by 152
Predicting drug-target interaction network using deep learning model
You, J., McLeod, R. D., & Hu, P. (2019) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2019.03.016 · Cited by 150
Steroid hormone biotransformation and xenobiotic induction of hepatic steroid metabolizing enzymes
You, L. (2004) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.01.006 · Cited by 145
TANNERGREN, C. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.12.012 · Cited by 138
Lee, L. S., Andrade, A. S. A., & Flexner, C. (2006) · Clinical Infectious Diseases · doi:10.1086/507894 · Cited by 102
Gurley, B. J., Swain, A., Hubbard, M. A., Hartsfield, F., Thaden, J., Williams, D. K., Gentry, W. B., & Tong, Y. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100222 · Cited by 102
GREGORETTI, B. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.04.020 · Cited by 56
Chiang, T.-S., Yang, K.-C., Chiou, L.-L., Huang, G.-T., & Lee, H.-S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094885 · Cited by 17
Metadata
- Authors
- Moore, L. B., Goodwin, B., Jones, S. A., Wisely, G. B., Serabjit-Singh, C. J., Willson, T. M., Collins, J. L., & Kliewer, S. A.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-06-13
- Volume
- 97
- Issue
- 13
- Pages
- 7500-7502
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2076985436
- Cited by
- 947
- References
- 23
- FWCI
- 46.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.